AddThis

Share

CVS enhances Hep C CareTeam

FDA approval of add-on therapies prompt company to expand program
June 3, 2011
CVS Caremark is enhancing its hepatitis C patient support program following the recent Food and Drug Administration approval of two new add-on therapies for hepatitis C, the company announced on Friday.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>
Related Terms:
Retail News
CVS
Latest News
Specialty Pharmacy
Health & Wellness
Top Retailers
Pharmacy
Retail Clinician
CVS Caremark
therapies for hepatitis C
Caremark Rx
Compliance
Computing
Concurrent Versions System
CVS Caremark
CVS/pharmacy
Economy of the United States
Food and Drug Administration
Gastroenterology
Harman On Time Radio
Hepatitis
Hepatitis C
Medicine
Pharmacist
Pharmacy
physician
Providence County, Rhode Island
Rhode Island
Scott Reid
© 2013 Drug Store News. All Rights Reserved.